Opinion|Videos|December 16, 2025
Dose Reducing and Sequencing Therapies in Desmoid Tumors
Experts discuss dose reduction strategies and emerging therapies for desmoid tumors, emphasizing patient monitoring and quality of life improvements.
Advertisement
Episodes in this series
Panelists discuss the questions below in this video.
- When is it appropriate to dose reduce with nirogacestat and how can this ensure the desired clinical outcomes are met?
- How are you sequencing therapies in your institution?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
2
RSV Vaccine Shows 100% Effectiveness in COPD: Jorgen Vestbo, MD
3
5 Things to Know About the 2026 ESC Heart Failure Guidelines
4
Enlicitide, Oral PCSK9 Inhibitor, Cuts LDL 60% in CORALreef Trials
5